Robert Ullman, MD
Cardiovascular Disease · Boca Raton, FLNPI 1548270739
Payments from drug & device makers
Across 23 payments — averaging $1486.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$34K
- Abbott$125
- Medtronic$119
- Biosense Webster, Inc.$101
- Sanofi-aventis U.S. LLC$44
- Shockwave Medical, Inc$38
- plus $47 from 2 others
What the payments were for
- Food & beverage$6012%
- Education$14,40042%
- Other$19,20056%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 9 | $33,727 |
| Abbott | 1 | $125 |
| Medtronic | 6 | $119 |
| Biosense Webster, Inc. | 1 | $101 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Shockwave Medical, Inc | 2 | $38 |
| Abiomed | 1 | $25 |
| BD | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$24,000
- EVLT$9,600
- CardioMEMS HF System$125
- Auryon Laser System 100-120 Vac$102
- Carto 3$101
How this compares
$34,201 in reported general payments places this provider in the 80th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 37 | $43,398 |
| BrilintaTicagrelor | 12 | $9,850 |
| Eplerenone | 18 | $1,476 |
| Potassium Chloride | 25 | $839 |
| Losartan Potassium | 67 | $707 |
| Metoprolol Succinate | 51 | $504 |
| Nifedipine ErNifedipine | 29 | $490 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $445 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 20 | $364 |
| Rosuvastatin Calcium | 27 | $351 |
| Amlodipine Besylate | 56 | $278 |
| Atorvastatin Calcium | 25 | $235 |
| Furosemide | 51 | $228 |
| Simvastatin | 12 | $190 |
| Ezetimibe | 13 | $169 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Boca Raton
- Seth BaumBoca Raton$11.1M
- David FuntBoca Raton$2.8M
- Michael KorenGainesville$31M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.